These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 7902980)

  • 1. Chronic nicotine treatment potentiates behavioral responses to dopaminergic drugs in rats.
    Suemaru K; Gomita Y; Furuno K; Araki Y
    Pharmacol Biochem Behav; 1993 Sep; 46(1):135-9. PubMed ID: 7902980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some behavioural effects of chloroquine in rats suggesting dopaminergic activation.
    Amabeoku GJ
    Indian J Med Res; 1994 Feb; 99():87-94. PubMed ID: 8005645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of yohimbine on dopamine dependent behaviours in rats and mice.
    Bende MM; Bapat TR; Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1990 Jul; 34(3):195-200. PubMed ID: 2286423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophrenia.
    Zemba Cilic A; Zemba M; Cilic M; Balenovic I; Strbe S; Ilic S; Vukojevic J; Zoricic Z; Filipcic I; Kokot A; Drmic D; Blagaic AB; Tvrdeic A; Seiwerth S; Sikiric P
    Behav Brain Res; 2021 Jan; 396():112919. PubMed ID: 32956773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of naloxone on methamphetamine and apomorphine stereotypy and on haloperidol catalepsy in rats.
    Balsara JJ; Nandal NV; Burte NP; Jadhav JH; Chandorkar AG
    Psychopharmacology (Berl); 1984; 82(3):237-40. PubMed ID: 6425907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic drugs influence the intensity of catalepsy induced by microinjections of carbachol into the reticular formation.
    Elazar Z; Ganchrow D; Paz M; Rabinowitz R; Paz Z; Korczyn AD
    Neurosci Lett; 1990 Nov; 119(2):245-8. PubMed ID: 1980731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat.
    Lipska BK; Weinberger DR
    Brain Res Dev Brain Res; 1993 Oct; 75(2):213-22. PubMed ID: 7903225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine potentiates the behavioral effects of haloperidol.
    Emerich DF; Norman AB; Sanberg PR
    Psychopharmacol Bull; 1991; 27(3):385-90. PubMed ID: 1775613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dihydroergotoxine on some dopamine-related behaviors in rats.
    Flório JC; Palermo-Neto J
    Gen Pharmacol; 1990; 21(4):411-5. PubMed ID: 2379797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic nicotine-induced changes in dopaminergic system: effect on behavioral response to dopamine agonist.
    Sershen H; Hashim A; Harsing L; Lajtha A
    Pharmacol Biochem Behav; 1991 Jun; 39(2):545-7. PubMed ID: 1682953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of buspirone on dopaminergic supersensitivity.
    Queiroz CM; Frussa-Filho R
    Life Sci; 1997; 61(4):371-82. PubMed ID: 9244363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phencyclidine-induced dopamine-dependent behaviors in chronic haloperidol-treated rats.
    Yamaguchi K; Nabeshima T; Amano M; Yoshida S; Furukawa H; Kameyama T
    Pharmacol Biochem Behav; 1985 Nov; 23(5):803-9. PubMed ID: 4080767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered response to apomorphine and haloperidol after nine days of cocaine injections.
    Epstein PN; Altshuler HL
    Pharmacol Biochem Behav; 1979 Feb; 10(2):189-93. PubMed ID: 572056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central dopaminergic actions of YM-14673, a new TRH analogue, in rodents.
    Yamamoto M; Ozawa Y; Sasamata M; Koshikawa N; Kobayashi M
    Eur J Pharmacol; 1990 May; 180(2-3):319-24. PubMed ID: 1973117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of the effect of ketamine on some dopaminergic behaviors in rats.
    Morato GS; Takahashi RN
    Braz J Med Biol Res; 1986; 19(3):403-9. PubMed ID: 3594006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual phenotype predicts nicotine-haloperidol interaction in catalepsy: possible implication for the therapeutic efficacy of nicotine in Tourette's syndrome.
    Boye SM
    Behav Brain Res; 2013 Jan; 236(1):30-34. PubMed ID: 22947904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.